SPYRE THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
SPYRE THERAPEUTICS, INC. (SYRE) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $703.97 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-08-04
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $703.97M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $419.20M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $440.89M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $276.69M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2026-06-30 | $703.97M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $419.20M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $440.89M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $276.69M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $327.76M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $367.11M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $338.44M 10-K · filed 2026-02-19 |
| 2024-09-30 | $253.61M 10-Q/A · filed 2024-11-18 |
| 2024-06-30 | $270.80M 10-Q/A · filed 2024-11-18 |
| 2024-03-31 | $191.09M 10-Q/A · filed 2024-11-18 |
| 2023-12-31 | $115.78M 10-K · filed 2025-02-27 |
| 2023-09-30 | $102.52M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.23M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $20.85M 10-K/A · filed 2024-11-18 |
| 2022-09-30 | $34.69M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $51.08M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $52.09M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $77.99M 10-K · filed 2023-03-02 |
| 2021-09-30 | $87.76M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $93.81M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $46.43M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $56.18M 10-K · filed 2022-03-08 |
| 2020-09-30 | $85.75M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $92.02M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $36.40M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $49.69M 10-K · filed 2021-03-18 |
| 2019-09-30 | $57.01M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $67.33M 10-Q · filed 2019-08-06 |
| 2018-12-31 | $52.05M 10-K · filed 2020-02-24 |
| 2018-09-30 | $50.20M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $51.61M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $32.72M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $34.50M 10-K · filed 2019-03-07 |
| 2017-09-30 | $26.62M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $34.47M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $39.08M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $15.75M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |